---
title: "HRAS"
date: 2023-05-13 00:00:00
layout: post
categories: Gene
summary: "## Gene Information"
tags: ['HRAS', 'gene', 'mutations', 'diseases', 'treatment', 'prognosis', 'drugresponse', 'cancerbiology']
---

## Gene Information

- Gene: HRAS
- Location: Chromosome 11 (11p15.5)
- Function: The HRAS gene encodes a GTPase protein that plays a role in cell signaling, cell growth, and differentiation.

## External IDs and Aliases

- HGNC: 5173
- NCBI Entrez Gene: 3265
- Ensembl: ENSG00000174775
- OMIM: 190020
- UniProtKB/Swiss-Prot: P01112
- Aliases: c-H-ras, H-Ras-1

## Mutations

- AA Mutation List: Some of the common HRAS mutations are:

  - G12V (dbSNP ID: rs121913529)
  - G13R (dbSNP ID: rs121913530)
  - Q61L (dbSNP ID: rs121913531)
  
- Mutation type: Missense mutation

## Somatic SNVs/InDels

- Some of the HRAS somatic mutations are:
  
  - c.37G>A (dbSNP ID: rs104894394)
  - c.182A>G (dbSNP ID: rs28630711)
  - c.163C>A (dbSNP ID: rs121913529)

## Related Diseases

- Costello syndrome
- Bladder cancer
- Lung adenocarcinoma
- Juvenile myelomonocytic leukemia
- Noonan syndrome

## Treatment and Prognosis

- Treatment: There are no specific drugs available for HRAS gene mutations. However, treatment for related diseases and symptoms such as cancer, heart defects, and developmental delays can be managed with surgery, chemotherapy, radiation therapy, and medication.
- Prognosis: The prognosis varies depending on the specific disease and the severity of the mutation.

## Drug Response

- There are currently no drugs specifically targeting HRAS gene mutations.

## Related Papers

- Subject: The role of HRAS mutations in cancer biology and targeted therapy.
  - Author: McCormick F.
  - DOI: 10.1016/j.cell.2018.02.042

- Subject: HRAS mutations in Costello syndrome: detection of constitutional activating mutations in codon 12 and 13 and loss of wild-type allele in malignancy.
  - Author: Kerr B et al.
  - DOI: 10.1002/1098-1004(2000)16:1<16::AID-HUMU4>3.0.CO;2-Q

**_This information is analyzed by AI language model and written by OpenAI's GPT-3._**